by JD Richards | Feb 14, 2021 | Blog Posts
Johnson and Johnson recently announced that they have met their COVID-19 vaccine trial’s primary endpoint. They are now seeking Emergency Use Authorization from the FDA for their one-dose vaccine for Sars-Cov-2 called JNJ-78436735 or Ad26.COV2.S by...
by JD Richards | Jan 8, 2021 | Blog Posts
On December 17, 2020, Moderna submitted a 54-page document to the FDA containing the data from their vaccine trials. When compared to Pfizer’s original data, there are some obvious differences although the two are using the same technology and had a similar...
